ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
Go back to ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test| PROPHASE LABS (NASDAQ: PRPH) | Delayed: 0.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $2.24 | |||
| Open | $0.36 | 52 Week Low | $1.08 | |||
| Day High | $0.36 | P/E | 18.00 | |||
| Day Low | $0.36 | EPS | $0.02 | |||
| Volume | 1,459 | |||||
